Bill Leonard, the esteemed former director of the Information Security Oversight Office and the principal overseer of the government secrecy system, now has his own blog where readers may look for his views and his insights on secrecy policy as the process of classification reform gets underway in earnest.
The House Judiciary Committee rebuffed a Republican proposal for a “resolution of inquiry” to require the Administration to produce documents concerning the use of Miranda warnings given to detainees captured in Afghanistan. The Committee’s adverse report, dated June 26, is available here.
The Defense Department has issued a newly updated policy statement (pdf) on reporting “questionable” intelligence activities. “It is DoD policy that senior leaders and policymakers within the Government be made aware of events that may erode the public trust in the conduct of DoD intelligence operations,” the June 17, 2009 memorandum states. Some such questionable activities are to be reported to the Intelligence Oversight Board, a component of the President’s Intelligence Advisory Board. However, the efficacy of any such reporting is limited by the fact that that Board currently has no sitting members. (“White House Intel Advisory Board Has No Members,” Secrecy News, June 15, 2009).
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.